Novel application of osteopontin polypeptide
A technology of osteopontin and standard products, applied in the new application field of osteopontin polypeptide
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Embodiment 1, the screening experiment of liver cancer marker
[0036] The experimental volunteers in this example include cancer patients, other cancer patients and healthy people, and the screening process of liver cancer markers refers to figure 1 shown. Based on the ELISA method, the serum samples provided by the experimental volunteers were fully exposed to the antibody chip coated with antibodies against 274 serum markers, and the artificial neural network analysis was performed on the test results of the antibody chip. Set 78 liver cancer samples, 40 other cancer samples and 80 healthy samples to normalize the data provided by the antibody chip. The standard product curve of the target factor is obtained by using the relevant standard product, and the protein concentration is determined according to the standard product curve. It was found that the content of 21 factors in liver cancer samples was significantly different from that in other cancer samples and ...
Embodiment 2
[0043] Embodiment 2, reverse protein chip operation steps
[0044] In this embodiment, the reverse protein chip technology is used to compare and analyze the 6 factors obtained in Example 1. The operation steps of the reverse protein chip are as follows:
[0045] Table 3, the reagent that the present embodiment adopts
[0046]
[0047]
[0048] (1) Sample processing: Serum samples provided by the experimenter were treated with appropriate buffer and serial dilution.
[0049] (2) Standard product preparation: prepare 6 factor recombinant proteins (see Table 3) to a concentration of 100g / ml (stock solution), dilute 5 times according to the initial concentration of each factor standard curve according to different 1 / 3 times, and set a blank control.
[0050] (3) Membrane preparation: the serum sample diluted in step (1), the gradient dilution standard prepared in step (2), positive control and blank control are spotted on the membrane; wherein, 800cw labeled streptavidi...
Embodiment 3
[0058] Embodiment 3, the preparation of stable OPN standard substance polypeptide
[0059] OPN is a protein composed of 314 amino acids, as shown in SEQ ID No.1 as follows:
[0060] MRIAVICFCL LGITCAIPVK QADSGSSEEK QLYNKYPDAV ATWLNPDPSQKQNLL APQNAVSSEETNDFKQETLPS KSNE SHDHMDDMDD EDDDDHVDSQ DSIDSNDSDD VDDTDDSHQSDESHHSDESD ELVTDFPTDL PATEVFTPVV PTVDTYDGRG DSVVYGLRSK SKKFRRPDIQ YPDATDEDITSHMESEELNG AYKAIPVAQD LNAPSDWDSR GKDSYETSQL DDQSAETHSH KQSRLYKRKA NDESNEHSDVIDSQELSKVS REFHSHEFHS HEDMLVVDPK KEEDKHLKFRI SHELDSAS SEVN
[0061] After a lot of research, the present invention finds that when the OPN recombinant protein is used as the calibrator to detect OPN in the sample, the stability of the standard product is worse than that of the natural protein due to the lack of glycosylation of the prokaryotic recombinantly expressed protein. Moreover, insoluble inclusion bodies are obtained during the purification of recombinant proteins, which are not easy to bind to specific antibo...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com